167 related articles for article (PubMed ID: 16817891)
21. Attenuated amyloid-beta aggregation and neurotoxicity owing to methionine oxidation.
Johansson AS; Bergquist J; Volbracht C; Päiviö A; Leist M; Lannfelt L; Westlind-Danielsson A
Neuroreport; 2007 Apr; 18(6):559-63. PubMed ID: 17413657
[TBL] [Abstract][Full Text] [Related]
22. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
[TBL] [Abstract][Full Text] [Related]
23. Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.
Lemkul JA; Bevan DR
J Phys Chem B; 2010 Feb; 114(4):1652-60. PubMed ID: 20055378
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses.
Lin MS; Chen LY; Tsai HT; Wang SS; Chang Y; Higuchi A; Chen WY
Langmuir; 2008 Jun; 24(11):5802-8. PubMed ID: 18452319
[TBL] [Abstract][Full Text] [Related]
25. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
Arimon M; Grimminger V; Sanz F; Lashuel HA
J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
[TBL] [Abstract][Full Text] [Related]
26. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
27. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
28. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
29. The Arctic Alzheimer mutation favors intracellular amyloid-beta production by making amyloid precursor protein less available to alpha-secretase.
Sahlin C; Lord A; Magnusson K; Englund H; Almeida CG; Greengard P; Nyberg F; Gouras GK; Lannfelt L; Nilsson LN
J Neurochem; 2007 May; 101(3):854-62. PubMed ID: 17448150
[TBL] [Abstract][Full Text] [Related]
30. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
Danielsson J; Pierattelli R; Banci L; Gräslund A
FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
Bieschke J; Siegel SJ; Fu Y; Kelly JW
Biochemistry; 2008 Jan; 47(1):50-9. PubMed ID: 18078350
[TBL] [Abstract][Full Text] [Related]
32. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
[TBL] [Abstract][Full Text] [Related]
33. Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform.
Bernstein SL; Wyttenbach T; Baumketner A; Shea JE; Bitan G; Teplow DB; Bowers MT
J Am Chem Soc; 2005 Feb; 127(7):2075-84. PubMed ID: 15713083
[TBL] [Abstract][Full Text] [Related]
34. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
Nagarajan S; Ramalingam K; Neelakanta Reddy P; Cereghetti DM; Padma Malar EJ; Rajadas J
FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
[TBL] [Abstract][Full Text] [Related]
35. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
[TBL] [Abstract][Full Text] [Related]
36. Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides.
Guo M; Gorman PM; Rico M; Chakrabartty A; Laurents DV
FEBS Lett; 2005 Jul; 579(17):3574-8. PubMed ID: 15964569
[TBL] [Abstract][Full Text] [Related]
37. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.
Necula M; Breydo L; Milton S; Kayed R; van der Veer WE; Tone P; Glabe CG
Biochemistry; 2007 Jul; 46(30):8850-60. PubMed ID: 17595112
[TBL] [Abstract][Full Text] [Related]
38. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
Juszczyk P; Kołodziejczyk AS; Grzonka Z
J Pept Sci; 2009 Jan; 15(1):23-9. PubMed ID: 19023881
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics studies of hexamers of amyloid-beta peptide (16-35) and its mutants: influence of charge states on amyloid formation.
Han W; Wu YD
Proteins; 2007 Feb; 66(3):575-87. PubMed ID: 17115426
[TBL] [Abstract][Full Text] [Related]
40. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
